Presentation of the Genome Valley Excellence Award 2023 followed by Keynote Address: Prof. Robert S. Langer, David H. Koch Institute Professor, Massachusetts Institute of Technology, USA
CEO Conclave Panel Discussion Future growth driver: What's next for India?
India continues to strengthen its foothold in the pharmaceutical industry – country’s leadership in generics was established long back, and COVID vaccines demonstrate industry’s success in rapid innovation capabilities.
What could drive the future growth for Indian pharmaceutical industry?
China plus one opportunity
Overcoming the uncertainty of global markets
Encouraging policy for enabling innovation and self-sustenance in KSMs and API (e.g., research linked incentives/RLI)
Further strengthen presence in biosimilars market
Contextualizing new areas (e.g. mRNA technology, CAR-T) to India and emerging markets
Chair: Mr. KT Rama Rao, Hon. Minister of I&C, Government of Telangana
Mr. Satish Reddy, Chairman, Dr. Reddy’s Laboratories
Mr. Ajay Piramal, Chairman, Piramal Group
Ms. Mahima Datla, Managing Director, Biological E Ltd.
Mr. Glenn Saldanha, Chairman and MD, Glenmark Pharmaceuticals
Mr. Hari S Bhartia, Founder and Co-Chairman, Jubilant Bhartia Group